MedTrace Logo

Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis

NCT01557868 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2014-04-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate whether the investigators can develop a computer algorithm to predict which individual patients will respond to injections of hyaluronic acid (HA) products for knee osteoarthritis.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

hylan G-F 20

Three 2 cc injections at weekly intervals

DEVICE

1% sodium hyaluronate

Three 2 cc injections at weekly intervals

Sponsors & Collaborators

  • United States Naval Medical Center, Portsmouth

    collaborator FED

  • American Orthopaedic Society for Sports Medicine

    lead OTHER

Principal Investigators

  • Robert Marx, MD · Hospital for Special Surgery, New York

  • Marlene DeMaio, MD · United States Naval Medical Center, Portsmouth

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01557868 on ClinicalTrials.gov